SANUWAVE Health, Inc. (SNWV)
NASDAQ: SNWV · Real-Time Price · USD
14.76
-0.63 (-4.09%)
Jun 5, 2026, 4:00 PM EDT - Market closed
SANUWAVE Health Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 16.49 | 11.81 | -33.08 | -25.81 | -10.29 | -27.26 |
Depreciation & Amortization | 1.32 | 1.28 | 1.15 | 1.03 | 0.95 | 1.24 |
Stock-Based Compensation | 5.58 | 4.85 | 1.51 | 0.22 | 0.89 | - |
Other Adjustments | -11.26 | -10.06 | 34.07 | 23.62 | -4.42 | 11.4 |
Change in Receivables | -2.34 | -2.3 | -0.49 | -0.05 | -1.75 | -0.4 |
Changes in Inventories | -1.01 | -2.28 | -1.2 | -2.8 | - | - |
Changes in Accounts Payable | -0.89 | -0.52 | -1.42 | 1.55 | -2.55 | 3.18 |
Changes in Accrued Expenses | 2.5 | 1.97 | 1.99 | -2.09 | 0.07 | 3.74 |
Changes in Other Operating Activities | -0.44 | -0.88 | -0.08 | -0.21 | -0.07 | 1.69 |
Operating Cash Flow | 2.47 | 3.88 | 2.46 | -4.54 | -17.17 | -6.41 |
Operating Cash Flow Growth | - | 57.88% | - | - | - | - |
Capital Expenditures | -1.77 | -1.94 | -0.49 | - | - | -0.53 |
Sale of Property, Plant & Equipment | - | - | - | 0.02 | 0.33 | - |
Purchases of Intangible Assets | -0.07 | - | - | - | - | - |
Proceeds from Sale of Intangible Assets | 0.38 | 5.38 | - | - | - | - |
Investing Cash Flow | 3.44 | 3.43 | -0.49 | 0.02 | 0.33 | -0.53 |
Short-Term Debt Issued | - | - | - | - | 0.64 | 0.18 |
Net Short-Term Debt Issued (Repaid) | - | - | - | - | 0.64 | 0.18 |
Long-Term Debt Issued | - | 23.66 | 1.8 | 6.02 | 19.17 | 3.9 |
Long-Term Debt Repaid | -29.19 | -29.19 | -4.05 | - | -2.98 | -0.49 |
Net Long-Term Debt Issued (Repaid) | -29.19 | -5.53 | -2.25 | 6.02 | 16.19 | 3.41 |
Issuance of Common Stock | 0.58 | 0.56 | 10.3 | - | 0.1 | - |
Net Common Stock Issued (Repurchased) | 0.58 | 0.56 | 10.3 | - | 0.1 | - |
Other Financing Activities | -0.19 | -0.61 | -1.7 | -0.81 | 0.46 | 1.54 |
Financing Cash Flow | -6.95 | -5.59 | 6.35 | 5.21 | 17.38 | 5.12 |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | - | - | 0.12 | -0.05 | -0.01 | -0 |
Net Cash Flow | 2.28 | 1.72 | 8.44 | 0.64 | 0.53 | -1.82 |
Free Cash Flow | 0.7 | 1.93 | 1.97 | -4.54 | -17.17 | -6.94 |
Free Cash Flow Growth | -63.91% | -1.58% | - | - | - | - |
FCF Margin | 1.57% | 4.39% | 6.02% | -22.25% | -102.55% | -53.33% |
Free Cash Flow Per Share | 0.08 | 0.21 | 0.44 | -2.14 | -11.72 | -5.02 |
Levered Free Cash Flow | -13.42 | 3.91 | -35.38 | -22.31 | 4.93 | -14.36 |
Unlevered Free Cash Flow | 2.58 | 2.6 | 3.79 | -3.06 | -10.55 | -4.82 |